ArticleJournal of human genetics2016
Evaluation of the evenness score in next-generation sequencing.
Article in Journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Evidence for balancing selection on loci associated with host use in the genome of a generalist plant parasite.Evolution letters · 2026Article
- MGDB: A Novel Bioinformatics Quality Control Tool for Clinical Next-Generation Sequencing.Cancer informatics · 2026Article
- Variation of and associations with the depth and evenness of sequencing coverage in archived plastid genomes.Scientific reports · 2025Article
- Variation of and associations with the depth and evenness of sequencing coverage in archived plastid genomes.Research square · 2025Article
- Evaluating the Transition from Targeted to Exome Sequencing: A Guide for Clinical Laboratories.International journal of molecular sciences · 2023Article
- Ultralow amounts of DNA from long-term archived serum samples produce high-quality methylomes.Clinical epigenetics · 2021Article
- Novel bioinformatics quality control metric for next-generation sequencing experiments in the clinical context.Nucleic acids research · 2019Article
- A commentary on evaluation of the evenness score in next-generation sequencing.Journal of human genetics · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The evenness score (E) in next-generation sequencing (NGS) quantifies the homogeneity in coverage of the NGS targets. Here I clarify the mathematical description of E, which is 1 minus the integral from 0 to 1 over the cumulative distribution function F(x) of the normalized coverage x, where normalization means division by the mean, and derive a computationally more efficient formula; that is, 1 minus the integral from 0 to 1 over the probability density distribution f(x) times 1-x. An analogous formula for empirical coverage data is provided as well as fast R command line scripts. This new formula allows for a general comparison of E with the coefficient of variation (=standard deviation σ of normalized data) which is the conventional measure of the relative width of a distribution. For symmetrical distributions, including the Gaussian, E can be predicted closely as 1-σ(2)/2⩾E⩾1-σ/2 with σ⩽1 owing to normalization and symmetry. In case of the log-normal distribution as a typical representative of positively skewed biological data, the analysis yields E≈exp(-σ*/2) with σ*(2)=ln(σ(2)+1) up to large σ (⩽3), and E≈1-F(exp(-1)) for very large σ (⩾2.5). In the latter kind of rather uneven coverage, E can provide direct information on the fraction of well-covered targets that is not immediately delivered by the normalized σ. Otherwise, E does not appear to have major advantages over σ or over a simple score exp(-σ) based on it. Actually, exp(-σ) exploits a much larger part of its range for the evaluation of realistic NGS outputs.
Indexed as
Identifiers
27074764What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.